AN2 Therapeutics Inc

+0.78 (+6.95%)
Earnings Announcements

AN2 Therapeutics Posts Quarterly Loss Per Share $2.98

Published: 05/10/2022 22:10 GMT
AN2 Therapeutics Inc (ANTX) - An2 Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Updates.
Expects Current Cash, Cash Equivalents and Investments, Will Be Sufficient to Fund Its Operating Expenses Through Mid-2024.
Qtrly Loss per Share $2.98.
Q1 Earnings per Share View $-0.52 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.54

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.52

More details on our Analysts Page.